Nestle SA according to recent updates has acquired Phagenesis, a U.K.-based maker of devices that help in treatment of dysphagia for £ 100 million in 2016. In addition, Nestle further sealed a joint venture with the Chinese Stroke Association in order to help patients with stroke swallow with less difficulty. Moreover, due to increasing availability of over-the-counter (OTC) over the drugs based on prescription will continue to inhibit growth of the global dysphagia management market in the coming years.
Factors propelling growth of the Global Market
While stroke features as the third leading cause of death and disability in Malaysia. Today, two-thirds of the people globally suffer from disabilities such as improper cognitive functioning, language and skills impairment. Malnutrition is another significant health-related problem that can be prevented with the right nutritional intervention. In parallel to the rapid growth in the healthcare and medical sector will witness a surge in growth in the span of next nine years. Such factors will further add to the list of factors escalating demand for the dysphagia management segment
With a surge in growing presence of retail pharmacies and specialty clinics will be significant distribution channel among others for the distribution of drugs related to dysphagia management and various treatment solutions. Whereas, hospital pharmacies will continue to be the leading segment among various distribution channels in the coming years. Moreover, the hospital pharmacies segment among other segments will account for US$ 1.5 Bn by the end of 2024. Furthermore, due to various side-effects of products sold as dysphagia tubes & drugs will restrain growth of the global dysphagia management market over the coming years. A major challenge for the global market includes losing out on the exclusivity of the market, which has incurred during sales of dysphagia drugs as OTC medications. The nutritional solutions segment among various types of products will retain dominance in the North America market of dysphagia management in the coming years. The nutritional solutions segment will represent the most lucrative market in the coming years. Whereas, the oropharangeal dysphagia among various indications will represent the most lucrative segment in the span of next nine years.
North America to Dominate the Global Market
The dysphagia management market in North America among various regions retained dominance globally in 2016, and is likely to retain dominance in the coming years. North America will further represent the most attractive region among others in the span of next nine years. In addition, Canada and U.S. among various countries in North America will play a vital role in the overall development of the dysphagia management market in North America in the coming years. The dysphagia management market in Canada will witness a growth of 5.7% CAGR due to growing awareness in the population regarding the treatment of dysphagia in the span of next nine years. Moreover, the nutritional solutions segment will represent the most lucrative segment in North America. The nutritional solutions segment retained dominance in terms of revenue in 2015, and will continue to dominate the global dysphagia management market over the coming years.
- R. Bard in the recent years has acquired various companies such as Medafor, Inc., Medicon, Inc., Lutonix, Inc., Neomend, Inc. and Medivance, Inc. Acquisition by C. R. Bard has led to increasing profits, and will continue to do so in the span of next nine years. While there are various methods and processes of treatment that are relatively fast as they are technically enhanced, however, dysphagia management solutions continue to witness significantly high demand in the coming years.
A sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/12988